Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4

Neurobiology of Aging

Volumn 19, Issue 6, 1998, Pages 511-515

  Klunk, William E ^a,b   Panchalingam, K ^a   McClure, R J ^a   Stanley, J A ^a   Pettegrew, J W ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Glycerophosphocholine; Glycerophosphoethanolamine; Membranes; Myo inositol; N Acetylaspartate; Nuclear magnetic resonance; Perchloric acid extracts; Phosphocholine; Phosphodiesters; Phosphoethanolamine; Phosphomonoesters; Phosphorus; Proton

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; GLYCEROPHOSPHOETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; MEMBRANE PHOSPHOLIPID; N ACETYLASPARTIC ACID; PHOSPHOETHANOLAMINE; PHOSPHOLIPID; PHOSPHORYLCHOLINE;

AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LIPID METABOLISM; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOLIPIDS;

EID: 0032450855     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(98)00105-5     Document Type: Article

References (40)

1. 1. Klunk, W. E.; Panchalingam, K.; Moossy, J.; McClure, R. J.; Pettegrew, J. W. N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study. Neurology 42:1578-1585; 1992.
2. 2. Kwo-On-Yuen, P. F.; Newmark, R. D.; Budinger, T. F.; Kaye, J. A.; Ball, M. J.; Jagust, W. J. Brain N-acetyl-L-aspartatic acid in Alzheimer's disease: A proton magnetic resonance spectroscopy study. Brain Res. 667:167-174; 1994.
3. 1H NMR study of the hippocampus and cerebellum. Journals of Gerontology Series A, Biological Sciences & Medical Sciences. 52:B111-B117; 1997.
4. 31P nuclear magnetic resonance study of the brain in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47:235-248; 1988.
5. 5. Pettegrew, J. W.; Panchalingam, K.; Moossy, J.; Martinez, J.; Rao, G.; Boller, F. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. Arch. Neurol. 45:1093-1096; 1988.
6. 31P magnetic resonance spectroscopy in Alzheimer's and Pick's disease. Neurobiol. Aging 14:85-92; 1993.
7. 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 39:1423-1427; 1989.
8. 8. Pettegrew, J. W.; Panchalingam, K.; Klunk, W. E.; McClure, R. J.; Muenz, L. R. Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study. Neurobiol. Aging 15:117-132; 1994.
9. 9. Cuenod, C.-A.; Kaplan, D. B.; Michot, J.-L.; Jehenson, P.; Leroy-Willig, A.; Forette, F.; Syrota, A.; Boller, F. Phospholipid abnormalities in early Alzheimer's disease. Arch. Neurol. 52:89-94; 1995.
10. 31P magnetic resonance spectroscopy of Alzheimer disease. Alzheimer's Disease & Associated Disorders. 10:46-52; 1996.
11. 31 metabolism in patients with senile dementia of Alzheimer type. Eur. Psychiatry 9:105-109, 1994.
12. 12. Shonk, T. K.; Moats, R. A.; Gifford, P.; Michaelis, T.; Mandigo, J. C.; Izumi, J.; Ross, B. D. Probable Alzheimer's disease: Diagnosis with proton MR spectroscopy. Radiology 195:65-72; 1995.
13. 13. MacKay, S.; Ezekiel, F.; Di, S. V.; Meyerhoff, D. J.; Gerson, J.; Norman, D.; Fein, G.; Weiner, M. W. Alzheimer's disease and subcortical ischemic vascular dementia: Evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 198:537-545; 1996.
14. 1H magnetic resonance spectroscopic imaging. Arch. Neurol. 53:167-174; 1996.
15. 15. Kattapong, V. J.; Brooks, W. M.; Wesley, M. H.; Kodituwakku, P. W.; Rosenberg, G. A. Proton magnetic resonance spectroscopy of vascular-and Alzheimer-type dementia. Arch. Neurol. 53:678-680; 1996.
16. 16. Heun, R.; Schlegel, S.; Graf-Morgenstern, M.; Tintera, J.; Gawehn, J.; Stoeter, P. Proton magnetic resonance spectroscopy in dementia of Alzheimer type. Int. J. Geriatr. Psychiatry 12:349-358; 1997.
17. 17. Ernst, T.; Chang, L.; Melchor, R.; Mehringer, C. M. Frontotemporal dementia and early Alzheimer's disease: Differentiation with frontal lobe H-1 MR spectroscopy. Radiology 203:829-836; 1997.
18. 18. Frederick, B. B.; Satlin, A.; Yurgelun-Todd, D. A.; Renshaw, P. F. In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes. Biol. Psychiatry 42:147-150; 1997.
19. 19. Corder, E. H.; Saunders, A. M.; Strittmatter, W. J.; Schmechel, D. E.; Gaskell, P. C.; Small, G. W.; Roses, A. D.; Haines, J. L.; Pericak-Vance, M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923; 1993.
20. 20. Saunders, A. M.; Strittmatter, W. J.; Schmechel, D.; George-Hyslop, P. H.; Pericak-Vance, M. A.; Joo, S. H.; Rosi, B. L.; Gusella, J. F.; Crapper-MacLachlan, D. R.; Alberts, M. J.; et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472; 1993.
21. 21. Saunders, A. M.; Schmader, K.; Breitner, J. C.; Benson, M. D.; Brown, W. T.; Goldfarb, L.; Goldgaber, D.; Manwaring, M. G.; Szymanski, M. H.; McCown, N.; Dole, K. C.; Schmechel, D. E.; Strittmatter, W. I.; Pericak-Vance, M. A.; Roses, A. D. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342:710-711; 1993.
22. 22. Poirier, J.; Davignon, J.; Bouthillier, D.; Kogan, S.; Bertrand, P.; Gauthier, S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342:697-699; 1993.
23. 23. Rebeck, G. W.; Reiter, J. S.; Strickland, D. K.; Hyman, B. T. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575-580; 1993.
24. 24. Mayeux, R.; Stern, Y.; Ottman, R.; Tatemichi, T. K.; Tang, M. X.; Maestre, G.; Ngai, C.; Tycko, B.; Ginsberg, H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol. 34:752-754; 1993.
25. 25. Brousseau, T.; Legrain, S.; Berr, C.; Gourlet, V.; Vidal, O.; Amouyel, P. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology 44:342-344; 1994.
26. 26. Ueki, A.; Kawano, M.; Namba, Y.; Kawakami, M.; Ikeda, K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with fate-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163:166-168; 1993.
27. 27. Roses, A. D. Apolipoprotein E affects the rate of Alzheimer's disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53:429-437; 1994.
28. 28. Schmechel, D. E.; Saunders, A. M.; Strittmatter, W. J.; Crain, B. J.; Hulette, C. M.; Joo, S. H.; Pericak-Vance, M. A.; Goldgaber, D.; Roses, A. D. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90:9649-9653; 1993.
29. 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol Aging 17:349-357; 1996.
30. 30. Khachaturian, Z. S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1097-1105; 1985.
31. 31. Moossy, J.; Zubenko, G.; Martinez, J.; Rao, G. R. Bilateral symmetry of morphologic lesions in Alzheimer's disease. Arch. Neurol. 45:251-254; 1988.
32. 32. Klunk, W. E.; Xu, C. J.; Panchalingam, K.; McClure, R. J.; Pettegrew, J. W. Analysis of magnetic resonance spectra by mole percent: Comparison to absolute units. Neurobiol. Aging 15:133-140; 1994.
33. 33. Mahley, R. W. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630; 1988.
34. 34. Masliah, E.; Mallory, M.; Veinbergs, I.; Miller, A.; Samuel, W. Alterations in apolipoprotein E expression during aging and neurodegeneration. Prog. Neurobiol. 50:493-503; 1996.
35. 31 in vivo NMR spectroscopy. Soc. Neurosci. Abstr. 16:843; 1990.
36. 36. Pettegrew, I. W.; Panchalingam, K.; Withers, G.; McKeag, D.; Strychor, S. Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat. J. Neuropathol. Exp. Neurol. 49:237-249; 1990.
37. 37. McClure, R. J.; Kanfer, I. N.; Panchalingam, K.; Klunk, W. E.; Pettegrew, J. W. Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease. In: George, A., ed. Neuroimaging Clinics of North America, 5 edition. Philadelphia: W.B. Saunders; 1995:69-85.
38. 38. Nitsch, R. M.; Blusztajn, J. K.; Pittas, A. G.; Slack, B. E.; Growdon, J. H.; Wurtman, R. J. Evidence for a membrane defect in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA 89:1671-1675; 1992.
39. 39. Klunk, W. E.; Xu, C. J.; McClure, R. J.; Panchalingam, K.; Stanley, J. A.; Pettegrew, J. W. Aggregation of β-amyloid peptide is promoted by membrane phospholipid metabolites elevated in Alzheimer's disease brain. J. Neurochem. 69:266-272; 1997.
40. 40. Mayeux, R.; Ottman, R.; Maestre, G.; Ngai, C.; Tang, M. X.; Ginsberg, H.; Chun, M.; Tycko, B.; Shelanski, M. Synergistic effects of traumatic head injury and apolipoprotein epsilon 4 in patients with Alzheimer's disease. Neurology 45:555-557; 1995.